Recursion Pharmaceuticals, Inc. (RXRX)

NASDAQ: RXRX · Real-Time Price · USD

3.360

-0.010 (-0.30%)

Mar 20, 2026, 11:11 AM EDT - Market open

Recursion Pharmaceuticals Revenue by Segment

Period Ending	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Operating	74.26M	43.42M	64.51M	59.82M	58.49M	64.60M	48.62M	45.23M
Operating Growth	26.96%	-32.80%	32.69%	32.24%	33.30%	37.66%	-2.52%	-2.76%
Grant	425.00K	274.00K	82.00K	-25.00K	351.00K	-	1.01M	1.00M
Grant Growth	21.08%	-	-91.91%	-	-49.79%	-	91,498.92%	-

Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.